TR201104738A2 - Pharmaceutical combination containing N-Acetylcysteine. - Google Patents

Pharmaceutical combination containing N-Acetylcysteine.

Info

Publication number
TR201104738A2
TR201104738A2 TR2011/04738A TR201104738A TR201104738A2 TR 201104738 A2 TR201104738 A2 TR 201104738A2 TR 2011/04738 A TR2011/04738 A TR 2011/04738A TR 201104738 A TR201104738 A TR 201104738A TR 201104738 A2 TR201104738 A2 TR 201104738A2
Authority
TR
Turkey
Prior art keywords
acetylcysteine
pharmaceutical combination
combination containing
combining
preparation
Prior art date
Application number
TR2011/04738A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2011/04738A priority Critical patent/TR201104738A2/en
Priority to PCT/TR2012/000082 priority patent/WO2013055302A1/en
Publication of TR201104738A2 publication Critical patent/TR201104738A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, bir mukolitik ajan olan N-Asetilsistein ile bir ksantin türevi bileşiğin kombine edilmesi ile hazırlanan farmasötik formülasyonlar, bunlarm hazırlanma yöntemi ve solunum yolu hastalıklarının tedavisinde kullanımı ile ilgilidir.The present invention relates to pharmaceutical formulations prepared by combining a mucolytic agent N-Acetylcysteine with a xanthine derivative compound, the method of preparation thereof and their use in the treatment of respiratory diseases.

TR2011/04738A 2011-05-16 2011-05-16 Pharmaceutical combination containing N-Acetylcysteine. TR201104738A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2011/04738A TR201104738A2 (en) 2011-05-16 2011-05-16 Pharmaceutical combination containing N-Acetylcysteine.
PCT/TR2012/000082 WO2013055302A1 (en) 2011-05-16 2012-05-14 Effervescent composition comprising n- acetylcysteine and doxophylline or theophylline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/04738A TR201104738A2 (en) 2011-05-16 2011-05-16 Pharmaceutical combination containing N-Acetylcysteine.

Publications (1)

Publication Number Publication Date
TR201104738A2 true TR201104738A2 (en) 2012-12-21

Family

ID=47430028

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/04738A TR201104738A2 (en) 2011-05-16 2011-05-16 Pharmaceutical combination containing N-Acetylcysteine.

Country Status (2)

Country Link
TR (1) TR201104738A2 (en)
WO (1) WO2013055302A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184505A (en) 1962-06-18 1965-05-18 Mead Johnson & Co Process for the n-monoacylation of cysteine
IT1113122B (en) 1978-04-06 1986-01-20 Abc Ist Biolog Chem Spa PHARMACEUTICAL COMPOSITION WITH ANTIBROCOSPASTIC AND ANTITOSSE ACTIVITIES
DE2842822C3 (en) * 1978-09-30 1982-05-19 Merz + Co GmbH & Co, 6000 Frankfurt Medicinal preparations of poorly soluble medicinal substances in the form of effervescent granules
CH667590A5 (en) * 1986-07-24 1988-10-31 Inpharzam Int Sa WATER-SOLUBLE EFFERVESCENT PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN. .
EP2130443A1 (en) * 2008-06-06 2009-12-09 Finzelberg GmbH & Co. KG Water-soluble extracts of Artemisia dracunculus (tarragon) for improvement of glucose metabolism
WO2011146031A1 (en) * 2010-05-18 2011-11-24 Bilgic Mahmut Pharmaceutical composition comprising n- acetylcysteine and a xanthine

Also Published As

Publication number Publication date
WO2013055302A9 (en) 2013-08-01
WO2013055302A1 (en) 2013-04-18

Similar Documents

Publication Publication Date Title
CY1124000T1 (en) SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES IN CRYSTALLINE FORM
EA201490947A1 (en) DERIVATIVES OF PURIN FOR THE TREATMENT OF VIRAL INFECTIONS
UA113651C2 (en) MACROCYCLIC PURINS FOR TREATMENT OF Viral INFECTIONS
CY1121736T1 (en) ARAMCHOL SALTS
EA201992133A1 (en) PIPERIDINO-PYRIMIDINE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS
EA201590343A1 (en) ALKYLPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES
EA201391719A1 (en) HINASOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES
EA201590667A1 (en) ACYLAMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
EA201590931A1 (en) HETEROCYCLIC SUBSTITUTED DERIVATIVES 2-AMINO-HINAZOLINE FOR THE TREATMENT OF VIRAL INFECTIONS
GB201106743D0 (en) Novel compounds
EA201300989A1 (en) AQUEOUS PHARMACEUTICAL COMPOSITION OF TAPENTADOL FOR Oral administration
EA201590161A1 (en) COMPOSITIONS OF ETHANRECEPT DIFFERENTLY DIFFERENT BY REDUCTION OF PARTICLES OF A REVERSIBLE RANGE
EA201400771A1 (en) NEW AZETIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION
MX2015004362A (en) Ketamine derivatives.
MX2013002948A (en) Pharmaceutical and nutraceutical compositions of abscisic acid.
RS53783B1 (en) An inhalable medicament comprising tiotropium
CO7160080A2 (en) Lipid compositions of racecadot
TR201903918T4 (en) Compositions containing a dispersing agent and their preparation.
CR20150019A (en) CARBAMATE DERIVATIVES / UREA
EA201590708A1 (en) MODIFIED HYALURONIC ACID DERIVATIVES AND THEIR APPLICATION
TR201009167A2 (en) Pharmaceutical granules containing cephalosporin.
EA201490573A1 (en) CONTAINING BENZOTHIAZOLONE
EA201791354A2 (en) PYRAMIDINDION DERIVATIVES PREPARATIONS
CY1122538T1 (en) CHONDROITIN COMPLEXES FOR TRANSCUTANEOUS ABSORPTION